WHO ICTRP trial
the effect of letrozole on endometrial thickness
IRCT20120104008611N14 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20120104008611N14 |
|---|---|
| Public title | the effect of letrozole on endometrial thickness |
| Scientific title | Investigating the effect of letrozole on endometrial thickness in IVF candidate patients at Yas Hospital infertility clinic |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Female Infertility. Female infertility |
| Interventions | Intervention 1: Intervention group:Patients receive letrozole 2.5 mg daily for 5 days from the third day of the menstrual cycle. Intervention 2: Control group: People receive daily placebo for 5 days from the third day of the menstrual… |
| Registration date | Jul 19, 2023 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: